Leukocyte cell-derived chemotaxin 2 antagonizes MET receptor activation to suppress hepatocellular carcinoma vascular invasion by protein tyrosine phosphatase 1B recruitment-Reference-Cited by-同舟云学术

Leukocyte cell-derived chemotaxin 2 antagonizes MET receptor activation to suppress hepatocellular carcinoma vascular invasion by protein tyrosine phosphatase 1B recruitment

Published:2014-01-16 Issue:3 Volume:59 Page:974-985
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Chen Chi-Kuan¹,Yang Ching-Yao¹²³,Hua Kuo-Tai¹⁴,Ho Ming-Chih²,Johansson Gunnar⁵,Jeng Yung-Ming⁶,Chen Chiung-Nien²³,Chen Min-Wei¹,Lee Wei-Jiunn⁷,Su Jen-Liang⁸⁹,Lai Tsung-Ching⁴,Chou Chi-Chi¹⁰,Ho Bing-Ching¹¹,Chang Chuan-Fa¹²,Lee Po-Huang²,Chang King-Jen²³¹³,Hsiao Michael⁴,Lin Ming-Tsan²¹⁴,Kuo Min-Liang¹¹⁵

Affiliation:

1. Graduate Institute of Toxicology; National Taiwan University College of Medicine; Taipei Taiwan

2. Department of Surgery; National Taiwan University Hospital, and National Taiwan University College of Medicine; Taipei Taiwan

3. Angiogenesis Research Center; National Taiwan University; Taipei Taiwan

4. Genomics Research Center; Academia Sinica; Taipei Taiwan

5. Department of Neurology; National Taiwan University Hospital, and National Taiwan University College of Medicine; Taipei Taiwan

6. Department of Pathology; National Taiwan University Hospital, and National Taiwan University College of Medicine; Taipei Taiwan

7. Department of Urology, Wan Fang Hospital; Taipei Medical University; Taipei Taiwan

8. National Institute of Cancer Research; National Health Research Institutes; Miaoli Taiwan

9. Department of Biotechnology; Asia University; Taichung Taiwan

10. Core Facilities for Protein Structural Analysis, Institute of Biological Chemistry; Academia Sinica, Nankang; Taipei Taiwan

11. NTU Center for Genomic Medicine; National Taiwan University College of Medicine; Taipei Taiwan

12. Department of Medical Laboratory Science and Biotechnology; National Cheng Kung University; Tainan Taiwan

13. Department of Surgery; Cheng Ching General Hospital; Taichung Taiwan

14. Department of Primary Care Medicine; National Taiwan University Hospital and National Taiwan University College of Medicine; Taipei Taiwan

15. Institute of Biochemical Science; National Taiwan University College of Life Science; Taipei Taiwan

Publisher

Wiley

Subject

Hepatology

Reference28 articles.

1. Targeting receptor tyrosine kinase pathways in hepatocellular carcinoma;Huynh;Anticancer Agents Med Chem,2011

2. A novel growth-promoting factor derived from fetal bovine cartilage, chondromodulin II. Purification and amino acid sequence;Hiraki;J Biol Chem,1996

3. Purification and primary amino acid sequence of a novel neutrophil chemotactic factor LECT2;Yamagoe;Immunol Lett,1996

4. Molecular cloning of human and bovine LECT2 having a neutrophil chemotactic activity and its specific expression in the liver;Yamagoe;Biochim Biophys Acta,1998

5. Identification of the leukocyte cell-derived chemotaxin 2 as a direct target gene of beta-catenin in the liver;Ovejero;Hepatology,2004

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Updates on the role of leukocyte cell-derived chemotaxin-2 in inflammation regulation and immunomodulation;Cytokine;2024-09

2. Global research trends and hotspots for leukocyte cell-derived chemotaxin-2 from the past to 2023: a combined bibliometric review;Frontiers in Immunology;2024-05-31

3. Loss of LECT2 promotes ovarian cancer progression by inducing cancer invasiveness and facilitating an immunosuppressive environment;Oncogene;2024-01-04

4. The emerging roles of leukocyte cell-derived chemotaxin-2 in immune diseases: From mechanisms to therapeutic potential;Frontiers in Immunology;2023-03-09

5. Targeting the cMET pathway to enhance immunotherapeutic approaches for mUM patients;Frontiers in Oncology;2023-01-24